Shanghai Pharmaceuticals Holding Co Ltd
F:S1R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
F:S1R
|
CN |
|
Industrivarden AB
F:IDV1
|
SE |
|
P
|
PPG Industries Inc
BMV:PPG
|
US |
|
Resona Holdings Inc
TSE:8308
|
JP |
|
B
|
BNP Paribas SA
LSE:0HB5
|
FR |
|
O
|
Oracle Corp
XHAM:ORC
|
US |
|
T
|
Tyson Foods Inc
F:TF7A
|
US |
|
State Street Corp
NYSE:STT
|
US |
|
Deutsche Bank AG
MIL:DBK
|
DE |
|
N
|
Northrop Grumman Corp
SWB:NTH
|
US |
|
N
|
Nexgen Energy Ltd
SWB:6NE
|
CA |
|
A
|
AMETEK Inc
SWB:AK1
|
US |
|
Roblox Corp
BMV:RBLX
|
US |
|
Mitsubishi Electric Corp
LSE:MEL
|
JP |
|
C
|
Continental AG
MIL:CON
|
DE |
|
S
|
Starwood Property Trust Inc
SWB:VSP
|
US |
|
C
|
ChipMOS Technologies Inc
TWSE:8150
|
TW |
|
B
|
BrainCool AB (publ)
F:5YL
|
SE |
|
Bright Smart Securities & Commodities Group Ltd
F:0BX
|
HK |
|
Thales SA
PAR:HO
|
FR |
|
Barings BDC Inc
NYSE:BBDC
|
US |
Wall St Price Targets
S1R Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for S1R is 1.67 EUR with a low forecast of 1.01 EUR and a high forecast of 2.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S1R's stock price target?
Price Target
1.67
EUR
According to Wall Street analysts, the average 1-year price target for S1R is 1.67 EUR with a low forecast of 1.01 EUR and a high forecast of 2.17 EUR.
What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 6%.
